-
公开(公告)号:US20120201749A1
公开(公告)日:2012-08-09
申请号:US13391686
申请日:2010-08-25
申请人: Melanie Jayne Crawshaw , Philip Spencer Fallon , Ashley Nicholas Jarvis , Jonathan Raymond Powell , Natalie Louise Winfield , David Selwood , Ian Charles Zachary , Haiyan Jia
发明人: Melanie Jayne Crawshaw , Philip Spencer Fallon , Ashley Nicholas Jarvis , Jonathan Raymond Powell , Natalie Louise Winfield , David Selwood , Ian Charles Zachary , Haiyan Jia
IPC分类号: A61K31/4535 , A61K31/496 , A61K31/4436 , C07D413/14 , A61K49/10 , A61P25/28 , A61P35/00 , A61P37/00 , A61K51/00 , C07D409/14 , A61K31/5377
CPC分类号: C07D417/12 , C07D333/36 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/14
摘要: Compounds of formula (I): or a pharmaceutically acceptable salt thereof, wherein: W is arylene, heteroarylene or formula (a) each L is independently alkylene, alkenylene, alkynylene, a direct bond, arylene, cycloalkylene, alkylene-arylene, alkylene-C═O or —C═O; each X is independently an N-containing heteroarylene, N-containing cycloalkylene or NR; Y is N-containing heteroaryl, N-containing cycloalkyl, NR2, OR1, CN or CO2R; Z1 is formula (b); are useful in therapy, particularly in the therapy of neurodegeneration and cancer.
摘要翻译: 式(I)化合物或其药学上可接受的盐,其中:W是亚芳基,亚杂芳基或式(a),每个L独立地是亚烷基,亚烯基,亚炔基,直接键,亚芳基,亚环烷基,亚烷基亚芳基, C = O或-C = O; 每个X独立地是含N的杂亚芳基,含N的亚环烷基或NR; Y是含N的杂芳基,含N的环烷基,NR2,OR1,CN或CO2R; Z1是式(b); 可用于治疗,特别是治疗神经变性和癌症。
-
公开(公告)号:US20100022525A1
公开(公告)日:2010-01-28
申请号:US12439523
申请日:2007-10-04
申请人: Haiyan Jia , Ian Zachary , Michelle Tickner , Lili Cheng , Chris Chapman , Katie Ellard , Basil Hartzoulakis , Ashley Jarvis , Rosemary Lynch , Jamie Nally , David Selwood , Mark Stewart
发明人: Haiyan Jia , Ian Zachary , Michelle Tickner , Lili Cheng , Chris Chapman , Katie Ellard , Basil Hartzoulakis , Ashley Jarvis , Rosemary Lynch , Jamie Nally , David Selwood , Mark Stewart
IPC分类号: A61K31/538 , A61K31/4436 , A61K31/41 , A61K31/381 , C07D265/36 , C07D409/12 , C07D285/10 , C07D333/36
CPC分类号: C07D333/38 , C07C279/12 , C07D277/56 , C07D307/68 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12
摘要: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
摘要翻译: 本发明是适合作为NP-1拮抗剂的式(I)或式(II)的化合物。
-
公开(公告)号:US20120122862A1
公开(公告)日:2012-05-17
申请号:US13361134
申请日:2012-01-30
申请人: Haiyan Jia , Ian Zachary , Michelle Tickner , Lili Cheng , Chris Chapman , Katie Ellard , Basil Hartzoulakis , Ashley Jarvis , Rosemary Lynch , Jamie Nally , David Selwood , Mark Stewart
发明人: Haiyan Jia , Ian Zachary , Michelle Tickner , Lili Cheng , Chris Chapman , Katie Ellard , Basil Hartzoulakis , Ashley Jarvis , Rosemary Lynch , Jamie Nally , David Selwood , Mark Stewart
IPC分类号: A61K31/538 , A61K31/197 , C07D333/38 , A61K31/381 , C07C311/46 , C07D277/56 , A61K31/426 , C07D307/68 , A61K31/341 , C07D417/12 , A61K31/433 , C07D409/12 , A61K31/4436 , C07D409/14 , C07D413/12 , C07D498/04 , A61K31/5383 , A61P25/00 , A61P25/28 , A61P35/00 , A61P37/02 , C07C279/14
CPC分类号: C07D333/38 , C07C279/12 , C07D277/56 , C07D307/68 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12
摘要: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
摘要翻译: 本发明是适合作为NP-1拮抗剂的式(I)或式(II)的化合物。
-
公开(公告)号:US07223835B2
公开(公告)日:2007-05-29
申请号:US10398616
申请日:2001-10-25
申请人: David Selwood , Ian Zachary , Haiyan Jia , Marianne Lohr , Dana Davis
发明人: David Selwood , Ian Zachary , Haiyan Jia , Marianne Lohr , Dana Davis
CPC分类号: C07K14/521 , A61K38/00
摘要: A peptide having part or all of the amino acid sequence QKRKRKKSRYKSWSVP (which is part of VEGF) has the ability to inhibit angiogenesis.
摘要翻译: 具有部分或全部氨基酸序列QKRKRKKSRYKSWSVP(其是VEGF的一部分)的肽具有抑制血管发生的能力。
-
公开(公告)号:US20120269864A1
公开(公告)日:2012-10-25
申请号:US13493110
申请日:2012-06-11
申请人: Haiyan Jia , Ian ZACHARY , Michelle TICKNER , Lili CHENG , Chris CHAPMAN , Katie ELLARD , Basil HARTZOULAKIS , Ashley JARVIS , Rosemary LYNCH , Jamie NALLY , David SELWOOD , Mark STEWART
发明人: Haiyan Jia , Ian ZACHARY , Michelle TICKNER , Lili CHENG , Chris CHAPMAN , Katie ELLARD , Basil HARTZOULAKIS , Ashley JARVIS , Rosemary LYNCH , Jamie NALLY , David SELWOOD , Mark STEWART
IPC分类号: A61K31/433 , A61K31/381 , C07D417/12 , C07D409/14 , A61K31/4436 , C07D413/12 , A61K31/538 , A61K31/506 , C07D498/04 , A61K31/5383 , A61K31/4245 , C07F5/02 , A61K31/69 , A61P25/28 , A61P25/00 , A61P35/00 , A61P37/02 , C07D409/12 , C07C279/14 , A61K31/197 , C07D277/56 , A61K31/4168 , C07D333/38
CPC分类号: C07D333/38 , C07C279/12 , C07D277/56 , C07D307/68 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12
摘要: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
摘要翻译: 本发明是适合作为NP-1拮抗剂的式(I)或式(II)的化合物。
-
公开(公告)号:US08227606B2
公开(公告)日:2012-07-24
申请号:US13361134
申请日:2012-01-30
申请人: Haiyan Jia , Ian Zachary , Michelle Tickner , Lili Cheng , Chris Chapman , Katie Ellard , Basil Hartzoulakis , Ashley Jarvis , Rosemary Lynch , Jamie Nally , David Selwood , Mark Stewart
发明人: Haiyan Jia , Ian Zachary , Michelle Tickner , Lili Cheng , Chris Chapman , Katie Ellard , Basil Hartzoulakis , Ashley Jarvis , Rosemary Lynch , Jamie Nally , David Selwood , Mark Stewart
IPC分类号: C07D417/14
CPC分类号: C07D333/38 , C07C279/12 , C07D277/56 , C07D307/68 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12
摘要: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
摘要翻译: 本发明是适合作为NP-1拮抗剂的式(I)或式(II)的化合物。
-
公开(公告)号:US08158789B2
公开(公告)日:2012-04-17
申请号:US12439523
申请日:2007-10-04
申请人: Haiyan Jia , Ian Zachary , Michelle Tickner , Lili Cheng , Chris Chapman , Katie Ellard , Basil Hartzoulakis , Ashley Jarvis , Rosemary Lynch , Jamie Nally , David Selwood , Mark Stewart
发明人: Haiyan Jia , Ian Zachary , Michelle Tickner , Lili Cheng , Chris Chapman , Katie Ellard , Basil Hartzoulakis , Ashley Jarvis , Rosemary Lynch , Jamie Nally , David Selwood , Mark Stewart
IPC分类号: C07D409/14
CPC分类号: C07D333/38 , C07C279/12 , C07D277/56 , C07D307/68 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12
摘要: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
摘要翻译: 本发明是适合作为NP-1拮抗剂的式(I)或式(II)的化合物。
-
-
-
-
-
-